- Home
- Products
- Customized ADCs
- CXCR4
- Anti-CXCR4-dasatinib ADC
Anti-CXCR4-dasatinib ADC (CAT#: ADC-W-520)
This ADC product is comprised of an anti-CXCR4 monoclonal antibody conjugated via a linker to dasatinib.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CXCR4
- Alternative Names
- CXCR4; chemokine (C-X-C motif) receptor 4; FB22; HM89; LAP3; LCR1; NPYR; WHIM; CD184; LAP-3; LESTR; NPY3R; NPYRL; HSY3RR; NPYY3R; D2S201E; C-X-C chemokine receptor type 4; fusin; CD184 antigen; SDF-1 receptor; LPS-associated protein 3; neuropeptide Y rece
- Target Entrez Gene ID
- 7852
- Target UniProt ID
- P61073
- Overview
- This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
- Overview
- Humanized Anti-CXCR4 Antibody
- Species Reactivity
- Human
- Name
- disulfide-cleavable linkers
- Name
- dasatinib
- Description
- Dasatinib, also known as BMS-354825, is a cancer drug. It is an oral Bcr-Abl tyrosine kinase inhibitorand Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD22-Mc-VC-PABC-MMAE ADC-8 (CAT#: ADC-W-193)
- Anti-TNFRSF10B (Tigatuzumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1884)
- Anti-IFNA1 (Rontalizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1219)
- Anti-FcRH5-SMCC-DM1 ADC-2 (CAT#: ADC-W-131)
- Anti-C. diff Toxin A (Actoxumab)-SPDB-DM4 ADC (CAT#: ADC-W-2049)
- Anti-IL23A (Guselkumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1351)
- Anti-ITGA4+ITGB7 (Crenezumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2502)
- Anti-EGFR (Modotuximab)-SMCC-DM1 ADC (CAT#: ADC-W-2336)
- Anti-CD33 (Lintuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-812)
- Anti-EDA-SS-DM1 ADC (CAT#: ADC-W-399)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-520. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-1925 | Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1927 | Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-386 | Anti-CXCR4 (ulocuplumab)-pAcF-MMAF ADC | p-acetyl phenylalanine (pAcF) | MMAF (Monomethyl auristatin F) |
| ADC-W-1923 | Anti-CXCR4 (Ulocuplumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-519 | Anti-CXCR4-PEG-S-4FB-dasatinib ADC | PEG-S-4FB linker | dasatinib |
| CAT# | Product Name | Linker | Payload |
| ADC-W-519 | Anti-CXCR4-PEG-S-4FB-dasatinib ADC | PEG-S-4FB linker | dasatinib |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
